82 related articles for article (PubMed ID: 16690533)
21. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids.
Defacque H; Piquemal D; Basset A; Marti J; Commes T
J Cell Physiol; 1999 Jan; 178(1):109-19. PubMed ID: 9886497
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway.
Huang Z; Li S; Fan W; Ma Q
Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms.
Turley JM; Falk LA; Ruscetti FW; Kasper JJ; Francomano T; Fu T; Bang OS; Birchenall-Roberts MC
Cell Growth Differ; 1996 Nov; 7(11):1535-44. PubMed ID: 8930403
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling.
Ding ZY; Jin GN; Liang HF; Wang W; Chen WX; Datta PK; Zhang MZ; Zhang B; Chen XP
Cell Signal; 2013 Oct; 25(10):1981-92. PubMed ID: 23727026
[TBL] [Abstract][Full Text] [Related]
26. Honey bee venom combined with 1,25-dihydroxyvitamin D
Mohseni-Kouchesfahani H; Nabioni M; Khosravi Z; Rahimi M
J Cancer Res Ther; 2017; 13(3):544-549. PubMed ID: 28862224
[TBL] [Abstract][Full Text] [Related]
27. Kaurenoic acid activates TGF-β signaling.
Kim KH; Han JW; Jung SK; Park BJ; Han CW; Joo M
Phytomedicine; 2017 Aug; 32():8-14. PubMed ID: 28732811
[TBL] [Abstract][Full Text] [Related]
28. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
29. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract][Full Text] [Related]
31. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression.
Chung KS; Cho SH; Shin JS; Kim DH; Choi JH; Choi SY; Rhee YK; Hong HD; Lee KT
Carcinogenesis; 2013 Feb; 34(2):331-40. PubMed ID: 23125221
[TBL] [Abstract][Full Text] [Related]
32. Cotylenin A and tyrosine kinase inhibitors synergistically inhibit the growth of chronic myeloid leukemia cells.
Ikejiri F; Honma Y; Okada T; Urano T; Suzumiya J
Int J Oncol; 2018 Jun; 52(6):2061-2068. PubMed ID: 29620253
[TBL] [Abstract][Full Text] [Related]
33. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
34. Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells.
Honma Y; Ishii Y; Sassa T; Asahi K
Leuk Res; 2003 Nov; 27(11):1019-25. PubMed ID: 12859995
[TBL] [Abstract][Full Text] [Related]
35. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
36. Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines.
Hussain AM; Lee HC; Chang CF
Eur J Cell Biol; 2000 Oct; 79(10):697-706. PubMed ID: 11089918
[TBL] [Abstract][Full Text] [Related]
37. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
38. Human eosinophils have an intact Smad signaling pathway leading to a major transforming growth factor-beta target gene expression.
Kanzaki M; Shibagaki N; Hatsushika K; Mitsui H; Inozume T; Okamoto A; Dobashi Y; Ogawa H; Shimada S; Nakao A
Int Arch Allergy Immunol; 2007; 142(4):309-17. PubMed ID: 17135762
[TBL] [Abstract][Full Text] [Related]
39. Synergistic combination therapy with cotylenin A and vincristine in multiple myeloma models.
Takahashi T; Honma Y; Miyake T; Adachi K; Takami S; Okada M; Kumanomidou S; Ikejiri F; Jo Y; Onishi C; Kawakami K; Moriyama I; Inoue M; Tanaka J; Suzumiya J
Int J Oncol; 2015 Apr; 46(4):1801-9. PubMed ID: 25672400
[TBL] [Abstract][Full Text] [Related]
40. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
